Related Experiment Video
Updated: Apr 12, 2026

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
Published on: May 10, 2021
Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease
Alessandro Mantovani1, Matteo Pernigo2, Corinna Bergamini2
1Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
Insights
Nonalcoholic fatty liver disease (NAFLD) is linked to heart valve calcification in type 2 diabetes patients. This study found NAFLD independently predicts aortic valve sclerosis and mitral annulus calcification, highlighting a significant cardiovascular risk connection.
Area of Science:
- Cardiology
- Hepatology
- Diabetology
Background:
- Aortic valve sclerosis (AVS) and mitral annulus calcification (MAC) are key indicators of poor cardiovascular outcomes in type 2 diabetes.
- The causes of valvular calcification remain unclear.
- Nonalcoholic fatty liver disease (NAFLD) is a growing cardiovascular risk factor, prevalent in type 2 diabetes.
Purpose of the Study:
- To investigate the association between NAFLD and valvular calcification (AVS and MAC) in type 2 diabetes patients.
- To determine if NAFLD is an independent predictor of cardiac calcification in this population.
Main Methods:
- A cross-sectional study involving 247 type 2 diabetic outpatients without prior heart or liver disease.
- Echocardiography was used to detect AVS and MAC.
- NAFLD was diagnosed using ultrasonography.
Main Results:
- Prevalence of NAFLD was 70.8%, increasing significantly with the severity of heart valve calcification (HVC).
- NAFLD was strongly associated with AVS and/or MAC (unadjusted OR 3.51, p < 0.001).
- This association remained significant after adjusting for multiple cardiovascular risk factors (adjusted OR 2.70, p < 0.01).
Conclusions:
- Nonalcoholic fatty liver disease is an independent predictor of cardiac calcification in both aortic and mitral valves.
- Findings suggest NAFLD plays a role in valvular calcification development in type 2 diabetes.
- Highlights the importance of screening for NAFLD in diabetic patients with valvular calcification.
Purpose:
Aortic valve sclerosis (AVS) and mitral annulus calcification (MAC) are two powerful predictors of adverse cardiovascular outcomes in patients with type 2 diabetes, but the etiology of valvular calcification is uncertain. Nonalcoholic fatty liver disease (NAFLD) is an emerging cardiovascular risk factor and is very common in type 2 diabetes, but whether NAFLD is associated with valvular calcification in this group of patients is presently unknown.
Methods:
We undertook a cross-sectional study of 247 consecutive type 2 diabetic outpatients with no previous history of heart failure, valvular heart diseases (aortic stenosis, mitral stenosis, moderate or severe aortic and mitral regurgitation) or hepatic diseases. Presence of MAC and AVS was detected by echocardiography. NAFLD was diagnosed by ultrasonography.
Results:
Overall, 139 (56.3%) patients had no heart valve calcification (HVC-0), 65 (26.3%) patients had one valve affected (HVC-1) and 43 (17.4%) patients had both valves affected (HVC-2). 175 (70.8%) patients had NAFLD and the prevalence of this disease markedly increased in patients with HVC-2 compared with either HVC-1 or HVC-0 (86.1% vs. 83.1% vs. 60.4%, respectively; p < 0.001). NAFLD was significantly associated with AVS and/or MAC (unadjusted-odds ratio 3.51, 95% CI 1.89-6.51, p < 0.001). Adjustments for age, sex, waist circumference, smoking, blood pressure, hemoglobin A1c, LDL-cholesterol, kidney function parameters, medication use and echocardiographic variables did not appreciably weaken this association (adjusted-odds ratio 2.70, 95% CI 1.23-7.38, p < 0.01).
Conclusions:
Our results show that NAFLD is an independent predictor of cardiac calcification in both the aortic and mitral valves in patients with type 2 diabetes.
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Heart Failure II: Pathophysiology
Coronary Artery Disease II: Pathophysiology
Mitral Stenosis IV: Nursing Management

